Cubresa secures BrainPET contract in Canada

2022 05 02 22 29 5432 2022 05 03 Cubresa Pet 20220502222447

Cubresa has secured a contract with Lawson Health Research Institute of London, Ontario, Canada, to supply the institute with its investigational BrainPET system.

Lawson will use BrainPET in neurological research studies in three areas:

  • Developing a way to differentiate between types of dementia using PET and MRI
  • Assessing a new method for "quantifying cognitive reserve" among the elderly
  • To explore changes in the density of synapses and the role of inflammation in psychiatric disorders, neurodegeneration and cognitive disability following a major cardiac event, the company said.
Cubresa BrainPET is an investigational device and is not available for commercial sale. Image courtesy of Cubresa.Cubresa BrainPET is an investigational device and is not available for commercial sale. Image courtesy of Cubresa.

BrainPET can be used with 1.5-tesla, 3-tesla, and 7-tesla MRI systems, Cubresa said.

Page 1 of 591
Next Page